Molecular basis of haemophilia A

Haemophilia, Supplement

Volumn 10, Issue 4, 2004, Pages 133-139

  Oldenburg, Johannes ^a,b,c   Ananyeva, N M ^d   Saenko, E L ^d  

^a Inst Transfus Med I   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Factor VIII protein; Genetic analysis; Haemophilia A; Mutation origin

Indexed keywords

BLOOD CLOTTING FACTOR 8; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PROTEOHEPARAN SULFATE; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ARTICLE; DRUG HALF LIFE; EMBRYO DEVELOPMENT; FREQUENCY ANALYSIS; GENE DELETION; GENE MUTATION; GENE REARRANGEMENT; GENETIC ANALYSIS; GENETIC COUNSELING; GERM CELL; HEMOPHILIA A; HUMAN; LIFE CYCLE; MEDICAL TECHNOLOGY; MISSENSE MUTATION; MOLECULAR BIOLOGY; MUTATIONAL ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SOMATIC MUTATION; STRUCTURE ACTIVITY RELATION; X CHROMOSOME;

EID: 11044230285     PISSN: 13550691     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2004.01005.x     Document Type: Article

References (51)

1. Strauss HS. The perpetuation of hemophilia by mutation. Pediatrics 1967; 39: 186-93.
2. Vogel F. A probable sex difference in some mutation rates. Am J Hum Genet 1977; 29: 312-9.
3. Becker J, Schwaab R, Möller-Taube A et al. Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type-dependent sex ratio of mutation frequencies. Am J Hum Genet 1996; 58: 657-70.
4. Lakich D, Kazazian HH, Antonarakis SE et al. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet 1993; 5: 236-41.
5. Naylor JA, Green PM, Rizza CR et al. Analysis of factor VIII mRNA defects in every one of 28 haemophilia A patients. Hum Mol Genet 1993; 2: 11-7.
6. Rossiter JP, Young M, Kimberland ML et al. Factor VIII gene inversions causing severe hemophilia A originate almost exclusively in male germ cells. Hum Mol Genet 1994; 3: 1035-9.
7. Driscol DJ, Migeon BR. Sex difference in methylation of single-copy genes in human meiotic germ cells: Implications for X chromosome inactivation, parental imprinting and origin of CpG mutations. Somat Cell Molec General 1990; 16: 267-82.
8. Vogel F, Motulsky AG. Population genetics. In: Vogel, F, Motulsky, AG, eds. Human Genetics. Berlin: Springer, 1986; 301-4.
9. El-Maarri O, Olek A, Balaban B et al. Methylation levels at selected CpG sites in the factor VIII and FGFR3 genes, in mature female and male germ cells: implications for male-driven evolution. Am J Hum Genet 1998; 63: 1001-8.
10. Shimmin CL, Chang BHJ, Li BH. Male-driven evolution of DNA sequences. Nature 1993; 362: 745-7.
11. Crow JF. Molecular evolution - who is in the driver's seat. Nat Genet 1997; 17: 129-30.
12. Leuer M, Oldenburg J, Lavergne JM et al. Somatic mosaicism in hemophilia A: a fairly common event. Am J Hum Genet 2001; 69: 75-87.
13. Cohn DH, Starman BJ, Blumberg B et al. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COLIAI). Am J Hum Genet 1990; 46: 591-601.
14. Toole JJ, Knopf JL, Woznwy JM et al. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 1984; 312: 342-7.
15. Vehar GA, Keyt B, Eaton D et al. Structure of human factor VIII. Nature 1984; 312: 337-41.
16. Oldenburg J. Mutation profiling in haemophilia A. Thromb Haemost 2001; 85: 577-9.
17. Vidal F, Farssac E, Altisent C et al. Rapid haemophilia A molecular diagnosis by a simple DNA sequencing procedure: Identification of 144 novel mutations. Thromb Haemost 2001; 85 580-3.
18. Kemball-Cook G, Tuddenham EGD, Wacey AI. The factor VIII structure and mutation resource site: HAMSTeRS, version 4. In: Nucl Acid Res 1998; 26: 216-9.
19. Bagnall RD, Waseem N, Green PM et al. Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A. Blood 2002; 99: 168-74.
20. Klopp N, Oldenburg J, Uen C et al. 11 hemophilia A patients without mutations in the factor VIII encoding gene. Thromb Haemost 2002; 88: 357-60.
21. Pattinson JK, Millar DS, McVey JH et al. The molecular genetic analysis of hemophilia A: a direct search strategy for the detection of point mutations in the factor VIII gene. Blood 1990; 76: 2242-8.
22. Cooper DN, Krawczak M. The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions. Hum Genet 1990; 85: 55-74.
23. Young M, Inaba H, Hoyer LW et al. Partial correction of a severe molecular defect in haemophilia A, because of errors during expression of the factor VIII gene. Am J Hum Genet 1997; 60: 565-73.
24. Mazurier C, Dieval J, Jorieux S et al. A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction. Blood 1990; 75: 20-6.
25. Gaucher C, Jorieux S, Mercier B et al. The 'Normandy' variant of von Willebrand disease: characterization of a point mutation in the von Willebrand factor gene. Blood 1991; 77: 1937-41.
26. Nichols WC, Seligsohn U, Zivelin A et al. Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell 1998; 93: 61-70.
27. Zhang B, Cunningham MA, Nichols WC et al. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nature Genet 2003; 34: 220-5.
28. Fay PJ. Regulation of factor VIIIa in the intrinsic factor Xase. Thromb Haemost 1999; 82: 193-200.
29. Saenko EL, Shima M, Sarafanov AG. Role of activation of the coagulation factor VIII in interaction with vWF, phospholipids, and functioning within the factor Xase complex. Trends Cardiovasc Med 1999; 9: 185-92.
30. Saenko EL, Ananyeva NM, Tuddenham EG et al. Factor VIII-novel insights into form and function. Br J Haematol 2002; 119: 323-31.
31. Moussalli M, Pipe SW, Hauri HP et al. Mannose-dependent endoplasmic reticulum (ER)-Golgi intermediate compartment-53-mediated ER to Golgi trafficking of coagulation factors V and VIII. J Biol Chem 1999; 274: 32539-42.
32. Cunningham MA, Pipe SW, Zhang B et al. LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII. J Thromb Haemost 2003; 1: 2360-7.
33. Pipe SW, Miao H, Tendulkar R et al. Asparagine-linked glycosylation sites within the B domain of coagulation factor VIII improve secretion efficiency. Blood 2001; 98: 705a.
34. Miao HZ, Sirachainan N, Palmer L et al. Bioengineering of coagulation factor VIII for improved secretion. Blood 2004; 103: 3412-9.
35. Pratt KP, Shen BW, Takeshima K et al. Structure of the C2 domain of human factor VIII at 1.5 A resolution. Nature 1999; 402: 439-42.
36. Stoilova-McPhie S, Villoutreix BO, Mertens K et al. Three-dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a three-dimentional density map derived by electron crystallography. Blood 2002; 99 1215-23.
37. Kolkman JA, Christophe OD, Lenting PJ et al. Surface loop 199-204 in blood coagulation factor IX is a cofactor-dependent site involved in macromolecular substrate interaction. J Biol Chem 1999; 274: 29087-93.
38. Sichler K, Kopetzki E, Huber R et al. Physiological fIXa activation involves a cooperative conformational rearrangement of the 99-loop. J Biol Chem 2003; 278: 4121-6.
39. Mutucumarana VP, Duffy EJ, Lollar P et al. The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa. A fluorescence study. J Biol Chem 1992; 267: 17012-21.
40. Fay PJ, Koshibu K. The A2 subunit of factor VIIIa modulates the active site of factor IXa. J Biol Chem 1998; 273: 19049-54.
41. Regan LM, Fay PJ. Cleavage of factor VIII light chain is required for maximal generation of factor VIIIa activity. J Biol Chem 1995; 270: 8546-52.
42. Saenko EL, Yakhyaev AV, Mikhailenko I et al. Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism. J Biol Chem 1999; 274: 37685-92.
43. Lenting P, Neels JG, van den Berg BM et al. The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein. J Biol Chem 1999; 274: 23734-9.
44. Ananyeva N, Kouiavskaia D, Shima M et al. Catabolism of the coagulation factor VIII. Can we prolong lifetime of fVIII in circulation? Trends Cardiovasc Med 2001; 11: 252-7.
45. Bovenschen N, Herz J, Grimbergen JM et al. Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency. Blood 2003; 101: 3933-9.
46. Sarafanov AG, Ananyeva NM, Shima M et al. Cell surface heparan sulfate proteoglycans participate in factor VIII catabolism mediated by low density lipoprotein receptor-related protein. J Biol Chem 2001; 276: 11970-9.
47. Bovenschen N, Boertjes RC, van Stempvoort G et al. Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIII. J Biol Chem 2003; 278: 9370-7.
48. Lenting PJ, van de Loo J-WHP, Donath M-JSH et al. The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX. J Biol Chem 1996; 271 1935-40.
49. Kouiavskaia DV, Ruiz JF, Strickand DK et al. Very low density lipoprotein receptor interacts with coagulation factor VIII. Blood 2003; 102: 88a.
50. Mertens K, Bovenschen N, Voorberg J et al. The endocytic receptors megalin and low-density lipoprotein receptor-related protein share binding to coagulation factor VIII. Blood 2003; 102: 89a.
51. Sarafanov AG, Makogonenko YM, Ananyeva NM et al. Identification of residues within the A2 domain of factor VIII critical for binding to low-density lipoprotein receptor-related protein. Blood 2003; 102: 541a.